Statins tied to lowered liver cancer risk with hepatitis C

By Genevra Pittman NEW YORK (Reuters Health) – People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking cholesterol-lowering drugs, new research from Taiwan suggests. The report doesn’t prove statins ward off cancer, and one researcher not involved in the study says it’s not reason enough to recommend using the popular medications solely for liver cancer prevention. Previous studies have come to ambiguous and conflicting conclusions on the question of statins’ cancer-preventing abilities, researchers noted. …